StockPriceToday
Gilead Sciences Inc (GILD)
About Gilead Sciences Inc
Gilead Sciences Inc. operates as a biopharmaceutical company that researches, develops, and commercializes medicines for areas of unmet medical need. The company's focus on antiviral treatments and innovative therapies has made GILD stock price sensitive to treatment efficacy data and market competition dynamics.
Gilead's antiviral portfolio includes treatments for HIV, hepatitis B, hepatitis C, and COVID-19, serving patients with serious viral infections worldwide. The company's expertise in antiviral drug development has established it as a leader in infectious disease treatments.
The company's expansion into oncology and inflammatory diseases through acquisitions and internal development demonstrates its commitment to diversifying beyond antiviral treatments. Gilead's CAR-T cell therapy products represent cutting-edge cancer treatments that command premium pricing, positively impacting GILD stock price trends.
Gilead's strong balance sheet and cash generation enable continued investment in research and development while returning capital to shareholders through dividends. The company's ability to successfully develop next-generation treatments while maintaining its market position in core therapeutic areas remains important for its long-term success.
GILD Stock 12 Month Chart
Latest News for GILD
Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
UBS Global Biopharma Conference 2026 November 17, 2026 5:00 AM ESTCompany ParticipantsAndrew Dickinson - Executive VP ...
Shares of Gilead Sciences Inc. GILD slid 1.05% to $167.95 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index SPX falling 0.35% to 7,592.40 ...
Other Popular Stocks
BioAge Labs Inc. is a biotechnology company developing therapies to target aging and age-related diseases.
Viant Technology Inc. (DSP) is a leading advertising technology company that operates a demand-side platform enabling advertisers to plan, buy, and measure digital advertising...
Apogee Enterprises Inc. designs and develops architectural glass products and systems for commercial construction markets.